InnovAge Holding Corp. (NASDAQ:INNV - Free Report) - Analysts at William Blair issued their Q1 2026 earnings estimates for InnovAge in a research report issued on Wednesday, September 10th. William Blair analyst J. Haase anticipates that the company will post earnings per share of $0.00 for the quarter. The consensus estimate for InnovAge's current full-year earnings is ($0.12) per share.
InnovAge (NASDAQ:INNV - Get Free Report) last released its quarterly earnings data on Tuesday, September 9th. The company reported ($0.01) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.02) by $0.01. InnovAge had a negative net margin of 3.55% and a negative return on equity of 11.80%. The firm had revenue of $221.42 million during the quarter, compared to analysts' expectations of $219.80 million. InnovAge has set its FY 2026 guidance at EPS.
InnovAge Price Performance
InnovAge stock opened at $4.15 on Thursday. InnovAge has a 12-month low of $2.60 and a 12-month high of $6.69. The stock has a market cap of $560.29 million, a P/E ratio of -18.04 and a beta of 0.52. The company has a 50-day moving average price of $3.80 and a 200 day moving average price of $3.56. The company has a current ratio of 0.78, a quick ratio of 0.78 and a debt-to-equity ratio of 0.04.
Institutional Investors Weigh In On InnovAge
A number of institutional investors have recently made changes to their positions in the stock. T. Rowe Price Investment Management Inc. increased its position in shares of InnovAge by 4.4% during the first quarter. T. Rowe Price Investment Management Inc. now owns 5,259,843 shares of the company's stock valued at $15,675,000 after acquiring an additional 222,155 shares during the last quarter. Kent Lake PR LLC increased its position in shares of InnovAge by 13.1% during the second quarter. Kent Lake PR LLC now owns 1,697,036 shares of the company's stock valued at $6,262,000 after acquiring an additional 197,036 shares during the last quarter. Geode Capital Management LLC increased its position in shares of InnovAge by 3.0% during the second quarter. Geode Capital Management LLC now owns 554,880 shares of the company's stock valued at $2,048,000 after acquiring an additional 16,205 shares during the last quarter. Welch Capital Partners LLC NY increased its position in shares of InnovAge by 22.6% during the second quarter. Welch Capital Partners LLC NY now owns 448,775 shares of the company's stock valued at $1,656,000 after acquiring an additional 82,868 shares during the last quarter. Finally, Northern Trust Corp increased its position in shares of InnovAge by 4.7% during the fourth quarter. Northern Trust Corp now owns 330,099 shares of the company's stock valued at $1,297,000 after acquiring an additional 14,900 shares during the last quarter. 12.26% of the stock is currently owned by institutional investors and hedge funds.
InnovAge Company Profile
(
Get Free Report)
InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in its homes and communities. The company manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach. It also offers in-home care services consisting of skilled, unskilled, and personal care; in-center services, such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to the PACE center and third-party medical appointments; and care management.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider InnovAge, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and InnovAge wasn't on the list.
While InnovAge currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.